Karen Wasilewski-Masker

Summary

Affiliation: Children's Healthcare of Atlanta
Country: USA

Publications

  1. pmc Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
    K Wasilewski-Masker
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, 5455 Meridian Mark Road, Suite 400, Atlanta, GA, 30342, USA
    J Cancer Surviv 8:437-47. 2014
  2. doi request reprint Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
  3. pmc Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
  4. doi request reprint Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
  5. doi request reprint Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0
    Jordan Gilleland
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    Psychooncology 22:2133-9. 2013
  6. doi request reprint Perceptions of body mass index (BMI) in pediatric cancer survivors and their providers
    Swati V Elchuri
    Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
    Pediatr Blood Cancer 61:1445-50. 2014
  7. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
  8. doi request reprint Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography
    A Blythe Ryerson
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    Pediatr Blood Cancer 62:502-8. 2015
  9. pmc Conditional survival in pediatric malignancies: Analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program
    Ann C Mertens
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia
    Cancer 121:1108-17. 2015
  10. doi request reprint Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program
    Briana C Patterson
    Emory University School of Medicine, Department of Pediatrics, M S, Emory Children s Center, 2015 Uppergate Drive, Suite 232 NE, Atlanta, Georgia 30322, USA
    J Clin Endocrinol Metab 97:810-8. 2012

Detail Information

Publications15

  1. pmc Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
    K Wasilewski-Masker
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, 5455 Meridian Mark Road, Suite 400, Atlanta, GA, 30342, USA
    J Cancer Surviv 8:437-47. 2014
    ..The purpose of this study was to assess the prevalence of male infertility and treatment-related risk factors in childhood cancer survivors...
  2. doi request reprint Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
    ....
  3. pmc Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
    ..We sought to estimate late recurrence rates for the most common pediatric cancers and to determine risk factors for late recurrence...
  4. doi request reprint Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
    ..0 (CTCAE) was designed for reporting acute and late effects of cancer treatment. To date, no study of pediatric-aged cancer survivors has graded health conditions using CTCAE, for patients in active follow-up in a cancer survivor program...
  5. doi request reprint Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0
    Jordan Gilleland
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    Psychooncology 22:2133-9. 2013
    ..This study aimed to examine clinical validity and utility of a screening measure for familial psychosocial risk, the Psychosocial Assessment Tool 2.0 (PAT2.0), among pediatric cancer survivors participating in long-term survivorship care...
  6. doi request reprint Perceptions of body mass index (BMI) in pediatric cancer survivors and their providers
    Swati V Elchuri
    Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
    Pediatr Blood Cancer 61:1445-50. 2014
    ..Perceptions of BMI status in cancer survivors have been understudied. This study determines the accuracy of parent/survivor and provider reporting of BMI status in a cancer survivor program...
  7. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
    ..Patients with relapsed pediatric sarcomas have a poor outcome and are in need of novel effective therapies...
  8. doi request reprint Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography
    A Blythe Ryerson
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    Pediatr Blood Cancer 62:502-8. 2015
    ..We examined childhood cancer survivors treated with anthracyclines during exercise using various echocardiography techniques to investigate if these tools can better detect subclinical cardiac dysfunction...
  9. pmc Conditional survival in pediatric malignancies: Analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program
    Ann C Mertens
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia
    Cancer 121:1108-17. 2015
    ..Long-term survivors of pediatric cancer are at risk of life-threatening late effects of their cancer. Previous studies have shown excesses in long-term mortality within high-risk groups defined by demographic and treatment characteristics...
  10. doi request reprint Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program
    Briana C Patterson
    Emory University School of Medicine, Department of Pediatrics, M S, Emory Children s Center, 2015 Uppergate Drive, Suite 232 NE, Atlanta, Georgia 30322, USA
    J Clin Endocrinol Metab 97:810-8. 2012
    ..Many pediatric cancer survivors have endocrine conditions. Surveillance for late effects is recommended by national guidelines. Endocrine surveillance is recommended after alkylating agents, steroids, methotrexate, and radiation...
  11. doi request reprint Adrenal function testing in pediatric cancer survivors
    Briana C Patterson
    Division of Endocrinology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 53:1302-7. 2009
    ..Central adrenal insufficiency is observed after cranial radiation therapy for cancer. Screening at risk patients is recommended, but the best screening strategy is unknown...
  12. pmc Factors associated with recruiting adult survivors of childhood cancer into clinic-based research
    Ann C Mertens
    Department of Pediatrics, Emory University, Children s Healthcare of Atlanta, Atlanta, Georgia
    Pediatr Blood Cancer 61:1846-51. 2014
    ..Little is known about the potential success of recruiting adult survivors of childhood cancer into research projects that would require a risk-based health evaluation within a clinical setting...
  13. doi request reprint Knowledge and risk perception of late effects among childhood cancer survivors and parents before and after visiting a childhood cancer survivor clinic
    Brooke Cherven
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    J Pediatr Oncol Nurs 31:339-49. 2014
    ..This suggests that perceived likelihood of developing a late effect is an important factor in the individuals' ability to learn about their risk and should be addressed before initiation of education. ..
  14. doi request reprint Intracavitary cisplatin therapy for pediatric malignancies
    Howard M Katzenstein
    AFLAC Cancer Center and Blood Disorders Services, Division of Pediatric Hematology Oncology, Emory University School of Medicine and Children s Healthcare of Atlanta, Atlanta, Georgia, USA
    Pediatr Blood Cancer 55:452-6. 2010
    ..The aim of the study was to determine the toxicity and efficacy of locally instilled intracavitary cisplatin in patients with recurrent tumors in closed body cavities...
  15. doi request reprint Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study
    Nina S Kadan-Lottick
    Section of Pediatric Hematology Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
    J Clin Oncol 26:3038-45. 2008
    ..Osteonecrosis (ON) is a potentially serious complication of therapy in survivors of childhood cancer. Our goals were to describe the incidence of ON and identify patient and treatment characteristics associated with elevated risk...